Neos Therapeutics, Inc. today announced that it will present new data for Adzenys XR-ODT (amphetamine) Extended-Release Orally-Disintegrating Tablets, at the 65th Annual Meeting of the American Academy of Child & Adolescent Psychiatry(AACAP), being held October 22-27, 2018 at the Washington State Convention Center in Seattle, Washington.
October 30, 2018
· 8 min read